ClearPoint Neuro CLPT Stock
ClearPoint Neuro Price Chart
ClearPoint Neuro CLPT Financial and Trading Overview
| ClearPoint Neuro stock price | 23.22 USD |
| Previous Close | 10.79 USD |
| Open | 10.98 USD |
| Bid | 10.75 USD x 100 |
| Ask | 10.93 USD x 100 |
| Day's Range | 10.73 - 11.06 USD |
| 52 Week Range | 7.31 - 19.22 USD |
| Volume | 132.24K USD |
| Avg. Volume | 412.05K USD |
| Market Cap | 307.21M USD |
| Beta (5Y Monthly) | 0.851 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.8 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 29 USD |
CLPT Valuation Measures
| Enterprise Value | 293.05M USD |
| Trailing P/E | N/A |
| Forward P/E | -17.817705 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 9.529923 |
| Price/Book (mrq) | 15.222409 |
| Enterprise Value/Revenue | 9.091 |
| Enterprise Value/EBITDA | -14.053 |
Trading Information
ClearPoint Neuro Stock Price History
| Beta (5Y Monthly) | 0.851 |
| 52-Week Change | 19.09% |
| S&P500 52-Week Change | 19.28% |
| 52 Week High | 19.22 USD |
| 52 Week Low | 7.31 USD |
| 50-Day Moving Average | 11.65 USD |
| 200-Day Moving Average | 13.47 USD |
CLPT Share Statistics
| Avg. Volume (3 month) | 412.05K USD |
| Avg. Daily Volume (10-Days) | 397.3K USD |
| Shares Outstanding | 28.27M |
| Float | 25.56M |
| Short Ratio | 3.76 |
| % Held by Insiders | 8.23% |
| % Held by Institutions | 35.78% |
| Shares Short | 2.07M |
| Short % of Float | 7.59% |
| Short % of Shares Outstanding | 7.34% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:40 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2024 |
| Most Recent Quarter (mrq) | March 31, 2025 |
| Next Fiscal Year End | December 31, 2025 |
Profitability
| Profit Margin | -64.50% |
| Operating Margin (ttm) | -72.63% |
| Gross Margin | 61.20% |
| EBITDA Margin | -64.68% |
Management Effectiveness
| Return on Assets (ttm) | -32.39% |
| Return on Equity (ttm) | -76.20% |
Income Statement
| Revenue (ttm) | 32.24M USD |
| Revenue Per Share (ttm) | 1.17 USD |
| Quarterly Revenue Growth (yoy) | 11.09% |
| Gross Profit (ttm) | 19.73M USD |
| EBITDA | -20853000 USD |
| Net Income Avi to Common (ttm) | -20794000 USD |
| Diluted EPS (ttm) | -0.76 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 12.39M USD |
| Total Cash Per Share (mrq) | 0.44 USD |
| Total Debt (mrq) | 3.44M USD |
| Total Debt/Equity (mrq) | 17.2 USD |
| Current Ratio (mrq) | 3.527 |
| Book Value Per Share (mrq) | 0.714 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -11282000 USD |
| Levered Free Cash Flow (ttm) | -2924125 USD |
Profile of ClearPoint Neuro
| Country | United States |
| State | CA |
| City | Solana Beach |
| Address | 120 S. Sierra Avenue |
| ZIP | 92075 |
| Phone | 888 287 9109 |
| Website | https://www.clearpointneuro.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 115 |
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V.; UCB Biopharma SRL; NE Scientific, LLC; and University of California, San Francisco, and Johns Hopkins University. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
Q&A For ClearPoint Neuro Stock
What is a current CLPT stock price?
ClearPoint Neuro CLPT stock price today per share is 23.22 USD.
How to purchase ClearPoint Neuro stock?
You can buy CLPT shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ClearPoint Neuro?
The stock symbol or ticker of ClearPoint Neuro is CLPT.
Which industry does the ClearPoint Neuro company belong to?
The ClearPoint Neuro industry is Medical Devices.
How many shares does ClearPoint Neuro have in circulation?
The max supply of ClearPoint Neuro shares is 28.43M.
What is ClearPoint Neuro Price to Earnings Ratio (PE Ratio)?
ClearPoint Neuro PE Ratio is now.
What was ClearPoint Neuro earnings per share over the trailing 12 months (TTM)?
ClearPoint Neuro EPS is -0.8 USD over the trailing 12 months.
Which sector does the ClearPoint Neuro company belong to?
The ClearPoint Neuro sector is Healthcare.
ClearPoint Neuro CLPT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 23724.96 USD — |
+0.61
|
9.88B USD — | 23628.82 USD — | 23946.23 USD — | — - | 9.88B USD — |
| US Tech Health Care IXHC | 1115.96 USD — |
+0.87
|
— — | 1099.74 USD — | 1117.62 USD — | — - | — — |
- {{ link.label }} {{link}}